Good ideas and conversation. No ads, no tracking. Login or Take a Tour!
As I understand it the Ebola vaccines haven't elicited much in the way of terrible side effects, but the trouble is that they've been given to thousands, not millions of patients. I think it's weaker efficacy, and not safety that have held up their approvals. Clearly with an ultra rare complication such as this one, it takes a hell of a lot of subjects to see a signal. Again, if it were me, I'd take the vaccine without hesitancy. We should expect the adverse even rate to decrease, not increase a year from now, because the AAV is not replication competent. Only time will tell though. This whole saga only seems to get stranger with time.